Revvity Inc. (NYSE:RVTY) Given Consensus Rating of “Hold” by Analysts

Revvity Inc. (NYSE:RVTY) has received an average recommendation of “Hold” from the thirteen brokerages that are presently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and four have given a buy recommendation to the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $107.7273.

A number of analysts have commented on the stock. Wells Fargo & Company upped their price objective on shares of Revvity from $107.00 to $110.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 3rd. Weiss Ratings lowered shares of Revvity from a “sell (d+)” rating to a “sell (d)” rating in a research report on Wednesday, May 13th. Wall Street Zen lowered shares of Revvity from a “buy” rating to a “hold” rating in a research report on Saturday, April 18th. The Goldman Sachs Group reduced their price target on shares of Revvity from $110.00 to $95.00 and set a “neutral” rating for the company in a research report on Tuesday, April 14th. Finally, JPMorgan Chase & Co. cut their price objective on shares of Revvity from $96.00 to $90.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 6th.

Revvity Stock Performance

NYSE:RVTY opened at $104.88 on Friday. Revvity has a twelve month low of $81.22 and a twelve month high of $118.30. The company has a current ratio of 1.72, a quick ratio of 1.41 and a debt-to-equity ratio of 0.37. The company has a 50-day moving average of $92.03 and a 200-day moving average of $97.23. The firm has a market cap of $11.70 billion, a price-to-earnings ratio of 50.18, a price-to-earnings-growth ratio of 2.18 and a beta of 1.05.

Revvity (NYSE:RVTY) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $1.06 earnings per share for the quarter, beating the consensus estimate of $1.02 by $0.04. Revvity had a net margin of 8.26% and a return on equity of 8.00%. The company had revenue of $711.12 million during the quarter, compared to analyst estimates of $704.07 million. During the same quarter last year, the firm posted $1.01 EPS. The business’s revenue for the quarter was up 7.0% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. Analysts forecast that Revvity will post 5.34 earnings per share for the current fiscal year.

Revvity Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Investors of record on Friday, July 17th will be given a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a yield of 0.3%. The ex-dividend date of this dividend is Friday, July 17th. Revvity’s dividend payout ratio (DPR) is presently 13.40%.

Hedge Funds Weigh In On Revvity

Several hedge funds and other institutional investors have recently added to or reduced their stakes in RVTY. EdgePoint Investment Group Inc. raised its position in Revvity by 26.3% during the third quarter. EdgePoint Investment Group Inc. now owns 8,574,280 shares of the company’s stock valued at $751,536,000 after acquiring an additional 1,784,620 shares in the last quarter. Allspring Global Investments Holdings LLC raised its position in Revvity by 127.0% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,751,612 shares of the company’s stock valued at $171,921,000 after acquiring an additional 980,142 shares in the last quarter. Norges Bank bought a new position in Revvity during the fourth quarter valued at approximately $80,382,000. Morgan Stanley raised its position in Revvity by 29.6% during the fourth quarter. Morgan Stanley now owns 2,844,464 shares of the company’s stock valued at $275,202,000 after acquiring an additional 650,083 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its position in Revvity by 39.0% during the third quarter. Dimensional Fund Advisors LP now owns 2,125,957 shares of the company’s stock valued at $186,307,000 after acquiring an additional 596,436 shares in the last quarter. Institutional investors own 86.65% of the company’s stock.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.